120 related articles for article (PubMed ID: 38745377)
1. Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model.
Tsuchitani T; Tomaru A; Aoki Y; Ishiguro N; Tsuda Y; Sugiyama Y
CPT Pharmacometrics Syst Pharmacol; 2024 May; ():. PubMed ID: 38745377
[TBL] [Abstract][Full Text] [Related]
2. Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans.
Ishiguro N; Maeda K; Kishimoto W; Saito A; Harada A; Ebner T; Roth W; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1109-15. PubMed ID: 16611857
[TBL] [Abstract][Full Text] [Related]
3. Revisiting Nonlinear Bosentan Pharmacokinetics by Physiologically Based Pharmacokinetic Modeling: Target Binding, Albeit Not a Major Contributor to Nonlinearity, Can Offer Prediction of Target Occupancy.
Koyama S; Toshimoto K; Lee W; Aoki Y; Sugiyama Y
Drug Metab Dispos; 2021 Apr; 49(4):298-304. PubMed ID: 33558262
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism.
Fukuchi Y; Toshimoto K; Mori T; Kakimoto K; Tobe Y; Sawada T; Asaumi R; Iwata T; Hashimoto Y; Nunoya KI; Imawaka H; Miyauchi S; Sugiyam Y
J Pharm Sci; 2017 Sep; 106(9):2704-2714. PubMed ID: 28465151
[TBL] [Abstract][Full Text] [Related]
5. Culture duration-, donor-, and medium-dependent changes in OATP1B3-mediated telmisartan uptake in human hepatocytes.
Zhu Q; Xia H; Xia CQ; Yang Q; Doshi U; Li AP; Liao M
Drug Metab Lett; 2014 Jul; 7(2):117-25. PubMed ID: 24628404
[TBL] [Abstract][Full Text] [Related]
6. A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept.
Sugiyama Y; Aoki Y
Drug Metab Dispos; 2023 Sep; 51(9):1067-1076. PubMed ID: 37407092
[TBL] [Abstract][Full Text] [Related]
7. The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan.
Takashima T; Hashizume Y; Katayama Y; Murai M; Wada Y; Maeda K; Sugiyama Y; Watanabe Y
Mol Pharm; 2011 Oct; 8(5):1789-98. PubMed ID: 21812443
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target-Mediated Drug Disposition Model.
Yuan X; An G
J Clin Pharmacol; 2024 Apr; ():. PubMed ID: 38652112
[TBL] [Abstract][Full Text] [Related]
10. Population Target-Mediated Pharmacokinetic/Pharmacodynamic Modeling to Evaluate SPI-62 Exposure and Hepatic 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibition in Healthy Adults.
Wu N; Katz DA; An G
Clin Pharmacokinet; 2023 Sep; 62(9):1275-1288. PubMed ID: 37452998
[TBL] [Abstract][Full Text] [Related]
11. [Dynamic analysis of pharmacokinetics of orally administered drugs using positron emission tomography].
Kataoka M
Yakugaku Zasshi; 2012; 132(8):911-7. PubMed ID: 22864349
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.
Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273
[TBL] [Abstract][Full Text] [Related]
13. Predicting In Vivo Target Occupancy (TO) Profiles via Physiologically Based Pharmacokinetic-TO Modeling of Warfarin Pharmacokinetics in Blood: Importance of Low Dose Data and Prediction of Stereoselective Target Interactions.
Lee W; Kim MS; Kim J; Aoki Y; Sugiyama Y
Drug Metab Dispos; 2023 Sep; 51(9):1145-1156. PubMed ID: 36914276
[TBL] [Abstract][Full Text] [Related]
14. Relative Activity Factor (RAF)-Based Scaling of Uptake Clearance Mediated by Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 in Human Hepatocytes.
Izumi S; Nozaki Y; Kusuhara H; Hotta K; Mochizuki T; Komori T; Maeda K; Sugiyama Y
Mol Pharm; 2018 Jun; 15(6):2277-2288. PubMed ID: 29746136
[TBL] [Abstract][Full Text] [Related]
15. Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3.
Shimizu K; Takashima T; Yamane T; Sasaki M; Kageyama H; Hashizume Y; Maeda K; Sugiyama Y; Watanabe Y; Senda M
Nucl Med Biol; 2012 Aug; 39(6):847-53. PubMed ID: 22421430
[TBL] [Abstract][Full Text] [Related]
16. Uridine 5'-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) Prediction of Hepatic Clearance of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Substrate Telmisartan by Glucuronidation Using In Vitro-In Vivo Extrapolation (IVIVE).
Gabor-Worwa E; Kowal-Chwast A; Gaud N; Gogola D; Littlewood P; Smoluch M; Brzózka K; Kus K
Eur J Drug Metab Pharmacokinet; 2024 May; 49(3):393-403. PubMed ID: 38642299
[TBL] [Abstract][Full Text] [Related]
17. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.
Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A
Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621
[TBL] [Abstract][Full Text] [Related]
18. Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans.
Bae SH; Park WS; Han S; Park GJ; Lee J; Hong T; Jeon S; Yim DS
Korean J Physiol Pharmacol; 2018 May; 22(3):321-329. PubMed ID: 29719454
[TBL] [Abstract][Full Text] [Related]
19. Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data.
Poirier A; Cascais AC; Funk C; Lavé T
Chem Biodivers; 2009 Nov; 6(11):1975-87. PubMed ID: 19937834
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
